Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose de Leon

Showing results (1-10 of 379) with videos related to

Pageof 38
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|October 9, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis: commentary, de LeonJose de Leon
Journal of Clinical Psychopharmacology|June 9, 2016
Pharmacogenetic Tests in Psychiatry: From Fear to Failure to HypeJose de Leon
Journal of Clinical Psychopharmacology|February 28, 2012
Evidence-based medicine versus personalized medicine: are they enemies?Jose de Leon
Journal of Clinical Psychopharmacology|September 14, 2018
Why Do You Keep Telling Me That Drug-Drug Interactions Are Important in Psychopharmacology When I Do Not See Them in My Clinical Practice?: My Failure to Convince CliniciansJose de Leon
Expert Opinion on Drug Metabolism & Toxicology|November 23, 2017
Have we successfully implemented CYP2D6 genotyping in psychiatry?Jose de Leon
Revista De Psiquiatria Y Salud Mental|June 27, 2015
The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part II: Pharmacological issues and further understandingJose de Leon
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 24, 2025
Prescribing clozapine to 10% of patients with schizophrenia may save 320,000 lives and cost 2400 deaths from agranulocytosisJose de Leon
Pharmacological Research|November 11, 2008
The future (or lack of future) of personalized prescription in psychiatryJose de Leon
Journal of Clinical Psychopharmacology|May 16, 2007
The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19Jose de Leon
The American Journal of Psychiatry|May 3, 2014
DSM-5 and the research domain criteria: 100 years after Jaspers' General psychopathologyJose de Leon
Pageof 38

Showing results (1-10 of 379) with videos related to

Sort By:
Pageof 38
The British Journal of Psychiatry : the Journal of Mental Science|October 9, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis: commentary, de LeonJose de Leon
Journal of Clinical Psychopharmacology|June 9, 2016
Pharmacogenetic Tests in Psychiatry: From Fear to Failure to HypeJose de Leon
Journal of Clinical Psychopharmacology|February 28, 2012
Evidence-based medicine versus personalized medicine: are they enemies?Jose de Leon
Journal of Clinical Psychopharmacology|September 14, 2018
Why Do You Keep Telling Me That Drug-Drug Interactions Are Important in Psychopharmacology When I Do Not See Them in My Clinical Practice?: My Failure to Convince CliniciansJose de Leon
Expert Opinion on Drug Metabolism & Toxicology|November 23, 2017
Have we successfully implemented CYP2D6 genotyping in psychiatry?Jose de Leon
Revista De Psiquiatria Y Salud Mental|June 27, 2015
The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part II: Pharmacological issues and further understandingJose de Leon
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 24, 2025
Prescribing clozapine to 10% of patients with schizophrenia may save 320,000 lives and cost 2400 deaths from agranulocytosisJose de Leon
Pharmacological Research|November 11, 2008
The future (or lack of future) of personalized prescription in psychiatryJose de Leon
Journal of Clinical Psychopharmacology|May 16, 2007
The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19Jose de Leon
The American Journal of Psychiatry|May 3, 2014
DSM-5 and the research domain criteria: 100 years after Jaspers' General psychopathologyJose de Leon
Pageof 38